Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,809 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pembrolizumab Retreatment in Patients with Advanced or Metastatic Urothelial Carcinoma Who Responded to First-course Pembrolizumab-based Therapy.
Koshkin VS, Danchaivijitr P, Bae WK, Semenov A, Ozyilkan O, Su YL, Arranz Arija JA, Tsujihata M, Bögemann M, Hendriks MP, Delgado SN, Rosenbaum E, Lopez KA, Bavle A, Liu CC, Imai K, Furka A. Koshkin VS, et al. Among authors: liu cc. Eur Urol. 2024 Dec 20:S0302-2838(24)02706-4. doi: 10.1016/j.eururo.2024.11.012. Online ahead of print. Eur Urol. 2024. PMID: 39709248
Cisplatin- or Carboplatin-Based Chemotherapy Plus Pembrolizumab in Advanced Urothelial Cancer: Exploratory Analysis From the Phase 3 KEYNOTE-361 Study.
Powles T, Csőszi T, Loriot Y, Matsubara N, Geczi L, Cheng SY, Fradet Y, Alva A, Oudard S, Vulsteke C, Morales-Barrera R, Fléchon A, Gunduz S, Liu CC, Moreno BH, Bavle A, Özgüroğlu M. Powles T, et al. Among authors: liu cc. Clin Genitourin Cancer. 2024 Nov 1;23(1):102261. doi: 10.1016/j.clgc.2024.102261. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 39642775
Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer Term Follow-Up from the Phase 3 KEYNOTE-240 Trial.
Merle P, Kudo M, Edeline J, Bouattour M, Cheng AL, Chan SL, Yau T, Garrido M, Knox J, Daniele B, Breder V, Lim HY, Ogasawara S, Cattan S, Chao Y, Siegel AB, Martinez-Forero I, Wei Z, Liu CC, Finn RS. Merle P, et al. Among authors: liu cc. Liver Cancer. 2023 Feb 14;12(4):309-320. doi: 10.1159/000529636. eCollection 2023 Sep. Liver Cancer. 2023. PMID: 37901200 Free PMC article.
Drug Development.
Raulin AC, Linares C, Alnobani A, Roy B, Crow A, Doss SV, Kuchenbecker LA, Dacquel MV, Karch CM, Martens YA, Liu CC, Bu G, Kanekiyo T. Raulin AC, et al. Among authors: liu cc. Alzheimers Dement. 2024 Dec;20 Suppl 6(Suppl 6):e093237. doi: 10.1002/alz.093237. Alzheimers Dement. 2024. PMID: 39782478 Free PMC article.
BNT162b2 mRNA vaccine elicits robust virus-specific antibodies but poor cross-protective CD8+ memory T cell responses in adolescents with type 1 diabetes.
Shen CF, Chang PD, Chou YY, Wang SW, Pan YW, Chen CA, Lin CW, Tsai BY, Tsai PJ, Liu CC, Cheng CM, Ko WC, Shieh CC; Taiwan Pediatric Infectious Disease Alliance (TPIDA). Shen CF, et al. Among authors: liu cc. J Microbiol Immunol Infect. 2025 Jan 3:S1684-1182(25)00001-5. doi: 10.1016/j.jmii.2024.12.009. Online ahead of print. J Microbiol Immunol Infect. 2025. PMID: 39765453
The UFMylation pathway is impaired in Alzheimer's disease.
Yan T, Heckman MG, Craver EC, Liu CC, Rawlinson BD, Wang X, Murray ME, Dickson DW, Ertekin-Taner N, Lou Z, Bu G, Springer W, Fiesel FC. Yan T, et al. Among authors: liu cc. Mol Neurodegener. 2024 Dec 18;19(1):97. doi: 10.1186/s13024-024-00784-y. Mol Neurodegener. 2024. PMID: 39696466 Free PMC article.
2,809 results